BackAlterola Biotech Overview

Alterola Biotech Total Current Liabilities

Track Alterola Biotech's total current liabilities ($2.5M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$2.52M
↑ 93.66% YoYΔ $1.22M vs prior year quarter

Peer trimmed avg / median

Loading

Alterola Biotech Total Current Liabilities History

Loading

Alterola Biotech vs. peers: Total Current Liabilities Comparison

Loading

Alterola Biotech Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Alterola Biotech (ABTI) FAQ

Alterola Biotech (ABTI) currently reports a total current liabilities of $2.5M as of September 2023. That compares with $1.3M in the prior-year period — up 93.7% year over year. Use the charts on this page to explore Alterola Biotech's total current liabilities history and peer comparisons.

Alterola Biotech's total current liabilities increased from $1.3M to $2.5M — a 93.7% year-over-year increase (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Alterola Biotech reported $2.5M in total current liabilities as of September 2023. That compares with $1.3M in the prior-year period — up 93.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $2.5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Alterola Biotech, and consider following ABTI for alerts when major investors trade the stock.

Questions & Answers